Education
About Us
Working with TipRanks
Follow Us
Meituan (MPNGF)
OTHER OTC:MPNGF
MPNGF Analyst Ratings
Moderate Buy
14 Buy
3 Hold
1 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
MPNGF Stock 12 Month Forecast
Average Price Target
$20.51
▲(33.70% Upside)
| Highest Price Target$23.95 | Average Price Target$20.51 | Lowest Price Target$14.65 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Citi
$24.46→$23.95
Buy
56.14%
Upside
Reiterated
08/05/25
TR | OpenAI - 4o
$16.82→$18.09
Buy
17.94%
Upside
Upgraded
07/20/25
UBS
$25.48→$21.91
Buy
42.85%
Upside
Reiterated
07/16/25
Jefferies
$21.02→$19.75
Buy
28.73%
Upside
Reiterated
07/14/25
J.P. Morgan
$20.38→$19.11
Buy
24.58%
Upside
Reiterated
07/11/25
HSBC
$20.38
Buy
32.89%
Upside
Reiterated
06/27/25
Macquarie
$14.65
Hold
-4.49%
Downside
Reiterated
06/24/25
Arete Research
$21.91
Hold
42.85%
Upside
Downgraded
06/24/25
Bernstein
$24.21→$19.11
Hold
24.58%
Upside
Downgraded
06/17/25
Nomura
$25.48→$22.42
Buy
46.17%
Upside
Reiterated
05/29/25
DBS
$26.25→$21.79
Buy
42.02%
Upside
Reiterated
05/27/25
Benchmark Co.
$26.75→$21.02
Buy
37.04%
Upside
Reiterated
05/27/25
CMB International Securities
$25.51→$23.14
Buy
50.83%
Upside
Reiterated
05/27/25
We remain positive on Meituan’s competitive edge in the FD industry, and believe industry competition should return to rationality in due course, but there will be a lack of visibility in the short term. We lower our 2025-2027E revenue/adj. NP forecasts by 1-2%/11-21% to account for the additional investment in the FD business, and incremental investment to support overseas expansion of the FD business. Our DCF-based TP was cut by 9% to HK$181.6 (previous: HK$200.20), translating into 25x 2025E adjusted PE. Maintain BUY. Proactively respond to competition and target to maintain market share. CLC segment rev/OP was 2%/10% better than consensus, thanks to better-than-expected UE expansion of FD aided by optimization in user subsidy.
Barclays
$15
Sell
-2.22%
Downside
Reiterated
05/27/25
CLSA
$24.84→$23.57
Buy
53.65%
Upside
Reiterated
05/27/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Citi
$24.46→$23.95
Buy
56.14%
Upside
Reiterated
08/05/25
TR | OpenAI - 4o
$16.82→$18.09
Buy
17.94%
Upside
Upgraded
07/20/25
UBS
$25.48→$21.91
Buy
42.85%
Upside
Reiterated
07/16/25
Jefferies
$21.02→$19.75
Buy
28.73%
Upside
Reiterated
07/14/25
J.P. Morgan
$20.38→$19.11
Buy
24.58%
Upside
Reiterated
07/11/25
HSBC
$20.38
Buy
32.89%
Upside
Reiterated
06/27/25
Macquarie
$14.65
Hold
-4.49%
Downside
Reiterated
06/24/25
Arete Research
$21.91
Hold
42.85%
Upside
Downgraded
06/24/25
Bernstein
$24.21→$19.11
Hold
24.58%
Upside
Downgraded
06/17/25
Nomura
$25.48→$22.42
Buy
46.17%
Upside
Reiterated
05/29/25
DBS
$26.25→$21.79
Buy
42.02%
Upside
Reiterated
05/27/25
Benchmark Co.
$26.75→$21.02
Buy
37.04%
Upside
Reiterated
05/27/25
CMB International Securities
$25.51→$23.14
Buy
50.83%
Upside
Reiterated
05/27/25
We remain positive on Meituan’s competitive edge in the FD industry, and believe industry competition should return to rationality in due course, but there will be a lack of visibility in the short term. We lower our 2025-2027E revenue/adj. NP forecasts by 1-2%/11-21% to account for the additional investment in the FD business, and incremental investment to support overseas expansion of the FD business. Our DCF-based TP was cut by 9% to HK$181.6 (previous: HK$200.20), translating into 25x 2025E adjusted PE. Maintain BUY. Proactively respond to competition and target to maintain market share. CLC segment rev/OP was 2%/10% better than consensus, thanks to better-than-expected UE expansion of FD aided by optimization in user subsidy.
Barclays
$15
Sell
-2.22%
Downside
Reiterated
05/27/25
CLSA
$24.84→$23.57
Buy
53.65%
Upside
Reiterated
05/27/25
Best Analysts Covering Meituan
1 Month
xxx
Success Rate
9/14 ratings generated profit
Average Return
-2.21%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 64.29% of your transactions generating a profit, with an average return of -2.21% per trade.
3 Months
xxx
Success Rate
7/14 ratings generated profit
Average Return
-4.94%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of -4.94% per trade.
1 Year
Success Rate
11/14 ratings generated profit
Average Return
+1.81%
reiterated a sell rating 3 months ago
Copying Jiong Shao's trades and holding each position for 1 Year would result in 78.57% of your transactions generating a profit, with an average return of +1.81% per trade.
2 Years
xxx
Success Rate
8/14 ratings generated profit
Average Return
+4.41%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 57.14% of your transactions generating a profit, with an average return of +4.41% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
MPNGF Analyst Recommendation Trends
Rating
Apr 25
May 25
Jun 25
Jul 25
Aug 25
Strong Buy
15
25
18
20
8
Buy
1
1
1
0
0
Hold
0
2
5
6
4
Sell
1
2
1
1
0
Strong Sell
0
0
0
0
0
total
17
30
25
27
12
Each month's total comprises the sum of three months' worth of ratings.
MPNGF Financial Forecast
MPNGF Stock Forecast FAQ
What is MPNGF’s average 12-month price target, according to analysts?
Based on analyst ratings, Meituan’s 12-month average price target is 20.51.
What is MPNGF’s upside potential, based on the analysts’ average price target?
Meituan has 33.70% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is MPNGF a Buy, Sell or Hold?
Meituan has a consensus rating of Moderate Buy which is based on 14 buy ratings, 3 hold ratings and 1 sell ratings.
What is Meituan’s price target?
The average price target for Meituan is 20.51. This is based on 18 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $23.95 ,the lowest forecast is $14.65. The average price target represents 33.70% Increase from the current price of $15.34.
The highest analyst price target is $23.95 ,the lowest forecast is $14.65. The average price target represents 33.70% Increase from the current price of $15.34.
What do analysts say about Meituan?
Meituan’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 18 Wall Streets Analysts.
How can I buy shares of MPNGF?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.